Global Oncolytic Virus Therapy Supply, Demand and Key Producers, 2024-2030

Description

The global Oncolytic Virus Therapy market size is expected to reach $ 28 million by 2030, rising at a market growth of 23.8% CAGR during the forecast period (2024-2030).

Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.

North America and Europe are the main markets, each accounting for about 40% of the market.

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

This report studies the global Oncolytic Virus Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oncolytic Virus Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncolytic Virus Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oncolytic Virus Therapy total market, 2019-2030, (USD Million)
Global Oncolytic Virus Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Oncolytic Virus Therapy total market, key domestic companies and share, (USD Million)
Global Oncolytic Virus Therapy revenue by player and market share 2019-2024, (USD Million)
Global Oncolytic Virus Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global Oncolytic Virus Therapy total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Oncolytic Virus Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics and Sorrento Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncolytic Virus Therapy market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Oncolytic Virus Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oncolytic Virus Therapy Market, Segmentation by Type
    HSV-based Oncolytic Viruses
    Adenoviruses-based Oncolytic Viruses
    Vaccinia Virus-based Oncolytic Viruses
    Vesicular Stomatitis Virus-based Oncolytic Viruses
    Newcastle Disease Virus-based Oncolytic Viruses

Global Oncolytic Virus Therapy Market, Segmentation by Application
    Melanoma
    Prostate Cancer
    Breast Cancer
    Ovarian Cancer
    Others

Companies Profiled:
    Amgen
    Oncolytics Biotech
    Viralytics
    Transgene SA
    Oncolys BioPharma
    Targovax
    PsiOxus Therapeutics
    SillaJen Biotherapeutics
    Sorrento Therapeutics
    Lokon Pharma
    Genelux Corporation
    Vyriad
    TILT Biotherapeutics
    Cold Genesys

Key Questions Answered
1. How big is the global Oncolytic Virus Therapy market?
2. What is the demand of the global Oncolytic Virus Therapy market?
3. What is the year over year growth of the global Oncolytic Virus Therapy market?
4. What is the total value of the global Oncolytic Virus Therapy market?
5. Who are the major players in the global Oncolytic Virus Therapy market?

Table of Contents

1 Supply Summary
    1.1 Oncolytic Virus Therapy Introduction
    1.2 World Oncolytic Virus Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Oncolytic Virus Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Oncolytic Virus Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Oncolytic Virus Therapy Market Size (2019-2030)
        1.3.3 China Oncolytic Virus Therapy Market Size (2019-2030)
        1.3.4 Europe Oncolytic Virus Therapy Market Size (2019-2030)
        1.3.5 Japan Oncolytic Virus Therapy Market Size (2019-2030)
        1.3.6 South Korea Oncolytic Virus Therapy Market Size (2019-2030)
        1.3.7 ASEAN Oncolytic Virus Therapy Market Size (2019-2030)
        1.3.8 India Oncolytic Virus Therapy Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oncolytic Virus Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oncolytic Virus Therapy Major Market Trends

2 Demand Summary
    2.1 World Oncolytic Virus Therapy Consumption Value (2019-2030)
    2.2 World Oncolytic Virus Therapy Consumption Value by Region
        2.2.1 World Oncolytic Virus Therapy Consumption Value by Region (2019-2024)
        2.2.2 World Oncolytic Virus Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States Oncolytic Virus Therapy Consumption Value (2019-2030)
    2.4 China Oncolytic Virus Therapy Consumption Value (2019-2030)
    2.5 Europe Oncolytic Virus Therapy Consumption Value (2019-2030)
    2.6 Japan Oncolytic Virus Therapy Consumption Value (2019-2030)
    2.7 South Korea Oncolytic Virus Therapy Consumption Value (2019-2030)
    2.8 ASEAN Oncolytic Virus Therapy Consumption Value (2019-2030)
    2.9 India Oncolytic Virus Therapy Consumption Value (2019-2030)

3 World Oncolytic Virus Therapy Companies Competitive Analysis
    3.1 World Oncolytic Virus Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Oncolytic Virus Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Oncolytic Virus Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for Oncolytic Virus Therapy in 2023
    3.3 Oncolytic Virus Therapy Company Evaluation Quadrant
    3.4 Oncolytic Virus Therapy Market: Overall Company Footprint Analysis
        3.4.1 Oncolytic Virus Therapy Market: Region Footprint
        3.4.2 Oncolytic Virus Therapy Market: Company Product Type Footprint
        3.4.3 Oncolytic Virus Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Oncolytic Virus Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Oncolytic Virus Therapy Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Oncolytic Virus Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Oncolytic Virus Therapy Consumption Value Comparison
        4.2.1 United States VS China: Oncolytic Virus Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Oncolytic Virus Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Oncolytic Virus Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based Oncolytic Virus Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Oncolytic Virus Therapy Revenue, (2019-2024)
    4.4 China Based Companies Oncolytic Virus Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based Oncolytic Virus Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Oncolytic Virus Therapy Revenue, (2019-2024)
    4.5 Rest of World Based Oncolytic Virus Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Oncolytic Virus Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Oncolytic Virus Therapy Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Oncolytic Virus Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 HSV-based Oncolytic Viruses
        5.2.2 Adenoviruses-based Oncolytic Viruses
        5.2.3 Vaccinia Virus-based Oncolytic Viruses
        5.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
        5.2.5 Newcastle Disease Virus-based Oncolytic Viruses
    5.3 Market Segment by Type
        5.3.1 World Oncolytic Virus Therapy Market Size by Type (2019-2024)
        5.3.2 World Oncolytic Virus Therapy Market Size by Type (2025-2030)
        5.3.3 World Oncolytic Virus Therapy Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Oncolytic Virus Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Melanoma
        6.2.2 Prostate Cancer
        6.2.3 Breast Cancer
        6.2.4 Ovarian Cancer
        6.2.5 Ovarian Cancer
    6.3 Market Segment by Application
        6.3.1 World Oncolytic Virus Therapy Market Size by Application (2019-2024)
        6.3.2 World Oncolytic Virus Therapy Market Size by Application (2025-2030)
        6.3.3 World Oncolytic Virus Therapy Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Details
        7.1.2 Amgen Major Business
        7.1.3 Amgen Oncolytic Virus Therapy Product and Services
        7.1.4 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Amgen Recent Developments/Updates
        7.1.6 Amgen Competitive Strengths & Weaknesses
    7.2 Oncolytics Biotech
        7.2.1 Oncolytics Biotech Details
        7.2.2 Oncolytics Biotech Major Business
        7.2.3 Oncolytics Biotech Oncolytic Virus Therapy Product and Services
        7.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Oncolytics Biotech Recent Developments/Updates
        7.2.6 Oncolytics Biotech Competitive Strengths & Weaknesses
    7.3 Viralytics
        7.3.1 Viralytics Details
        7.3.2 Viralytics Major Business
        7.3.3 Viralytics Oncolytic Virus Therapy Product and Services
        7.3.4 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Viralytics Recent Developments/Updates
        7.3.6 Viralytics Competitive Strengths & Weaknesses
    7.4 Transgene SA
        7.4.1 Transgene SA Details
        7.4.2 Transgene SA Major Business
        7.4.3 Transgene SA Oncolytic Virus Therapy Product and Services
        7.4.4 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Transgene SA Recent Developments/Updates
        7.4.6 Transgene SA Competitive Strengths & Weaknesses
    7.5 Oncolys BioPharma
        7.5.1 Oncolys BioPharma Details
        7.5.2 Oncolys BioPharma Major Business
        7.5.3 Oncolys BioPharma Oncolytic Virus Therapy Product and Services
        7.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Oncolys BioPharma Recent Developments/Updates
        7.5.6 Oncolys BioPharma Competitive Strengths & Weaknesses
    7.6 Targovax
        7.6.1 Targovax Details
        7.6.2 Targovax Major Business
        7.6.3 Targovax Oncolytic Virus Therapy Product and Services
        7.6.4 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Targovax Recent Developments/Updates
        7.6.6 Targovax Competitive Strengths & Weaknesses
    7.7 PsiOxus Therapeutics
        7.7.1 PsiOxus Therapeutics Details
        7.7.2 PsiOxus Therapeutics Major Business
        7.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Product and Services
        7.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 PsiOxus Therapeutics Recent Developments/Updates
        7.7.6 PsiOxus Therapeutics Competitive Strengths & Weaknesses
    7.8 SillaJen Biotherapeutics
        7.8.1 SillaJen Biotherapeutics Details
        7.8.2 SillaJen Biotherapeutics Major Business
        7.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Services
        7.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 SillaJen Biotherapeutics Recent Developments/Updates
        7.8.6 SillaJen Biotherapeutics Competitive Strengths & Weaknesses
    7.9 Sorrento Therapeutics
        7.9.1 Sorrento Therapeutics Details
        7.9.2 Sorrento Therapeutics Major Business
        7.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Product and Services
        7.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Sorrento Therapeutics Recent Developments/Updates
        7.9.6 Sorrento Therapeutics Competitive Strengths & Weaknesses
    7.10 Lokon Pharma
        7.10.1 Lokon Pharma Details
        7.10.2 Lokon Pharma Major Business
        7.10.3 Lokon Pharma Oncolytic Virus Therapy Product and Services
        7.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Lokon Pharma Recent Developments/Updates
        7.10.6 Lokon Pharma Competitive Strengths & Weaknesses
    7.11 Genelux Corporation
        7.11.1 Genelux Corporation Details
        7.11.2 Genelux Corporation Major Business
        7.11.3 Genelux Corporation Oncolytic Virus Therapy Product and Services
        7.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Genelux Corporation Recent Developments/Updates
        7.11.6 Genelux Corporation Competitive Strengths & Weaknesses
    7.12 Vyriad
        7.12.1 Vyriad Details
        7.12.2 Vyriad Major Business
        7.12.3 Vyriad Oncolytic Virus Therapy Product and Services
        7.12.4 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Vyriad Recent Developments/Updates
        7.12.6 Vyriad Competitive Strengths & Weaknesses
    7.13 TILT Biotherapeutics
        7.13.1 TILT Biotherapeutics Details
        7.13.2 TILT Biotherapeutics Major Business
        7.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Product and Services
        7.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 TILT Biotherapeutics Recent Developments/Updates
        7.13.6 TILT Biotherapeutics Competitive Strengths & Weaknesses
    7.14 Cold Genesys
        7.14.1 Cold Genesys Details
        7.14.2 Cold Genesys Major Business
        7.14.3 Cold Genesys Oncolytic Virus Therapy Product and Services
        7.14.4 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Cold Genesys Recent Developments/Updates
        7.14.6 Cold Genesys Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oncolytic Virus Therapy Industry Chain
    8.2 Oncolytic Virus Therapy Upstream Analysis
    8.3 Oncolytic Virus Therapy Midstream Analysis
    8.4 Oncolytic Virus Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oncolytic Virus Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Oncolytic Virus Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Oncolytic Virus Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Oncolytic Virus Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Oncolytic Virus Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Oncolytic Virus Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Oncolytic Virus Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Oncolytic Virus Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Oncolytic Virus Therapy Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Oncolytic Virus Therapy Players in 2023
    Table 12. World Oncolytic Virus Therapy Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Oncolytic Virus Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Oncolytic Virus Therapy Player
    Table 15. Oncolytic Virus Therapy Market: Company Product Type Footprint
    Table 16. Oncolytic Virus Therapy Market: Company Product Application Footprint
    Table 17. Oncolytic Virus Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Oncolytic Virus Therapy Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Oncolytic Virus Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Oncolytic Virus Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Oncolytic Virus Therapy Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Oncolytic Virus Therapy Revenue Market Share (2019-2024)
    Table 23. China Based Oncolytic Virus Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Oncolytic Virus Therapy Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Oncolytic Virus Therapy Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Oncolytic Virus Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Oncolytic Virus Therapy Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Oncolytic Virus Therapy Revenue Market Share (2019-2024)
    Table 29. World Oncolytic Virus Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Oncolytic Virus Therapy Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Oncolytic Virus Therapy Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Oncolytic Virus Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Oncolytic Virus Therapy Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Oncolytic Virus Therapy Market Size by Application (2025-2030) & (USD Million)
    Table 35. Amgen Basic Information, Area Served and Competitors
    Table 36. Amgen Major Business
    Table 37. Amgen Oncolytic Virus Therapy Product and Services
    Table 38. Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Amgen Recent Developments/Updates
    Table 40. Amgen Competitive Strengths & Weaknesses
    Table 41. Oncolytics Biotech Basic Information, Area Served and Competitors
    Table 42. Oncolytics Biotech Major Business
    Table 43. Oncolytics Biotech Oncolytic Virus Therapy Product and Services
    Table 44. Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Oncolytics Biotech Recent Developments/Updates
    Table 46. Oncolytics Biotech Competitive Strengths & Weaknesses
    Table 47. Viralytics Basic Information, Area Served and Competitors
    Table 48. Viralytics Major Business
    Table 49. Viralytics Oncolytic Virus Therapy Product and Services
    Table 50. Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Viralytics Recent Developments/Updates
    Table 52. Viralytics Competitive Strengths & Weaknesses
    Table 53. Transgene SA Basic Information, Area Served and Competitors
    Table 54. Transgene SA Major Business
    Table 55. Transgene SA Oncolytic Virus Therapy Product and Services
    Table 56. Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Transgene SA Recent Developments/Updates
    Table 58. Transgene SA Competitive Strengths & Weaknesses
    Table 59. Oncolys BioPharma Basic Information, Area Served and Competitors
    Table 60. Oncolys BioPharma Major Business
    Table 61. Oncolys BioPharma Oncolytic Virus Therapy Product and Services
    Table 62. Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Oncolys BioPharma Recent Developments/Updates
    Table 64. Oncolys BioPharma Competitive Strengths & Weaknesses
    Table 65. Targovax Basic Information, Area Served and Competitors
    Table 66. Targovax Major Business
    Table 67. Targovax Oncolytic Virus Therapy Product and Services
    Table 68. Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Targovax Recent Developments/Updates
    Table 70. Targovax Competitive Strengths & Weaknesses
    Table 71. PsiOxus Therapeutics Basic Information, Area Served and Competitors
    Table 72. PsiOxus Therapeutics Major Business
    Table 73. PsiOxus Therapeutics Oncolytic Virus Therapy Product and Services
    Table 74. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. PsiOxus Therapeutics Recent Developments/Updates
    Table 76. PsiOxus Therapeutics Competitive Strengths & Weaknesses
    Table 77. SillaJen Biotherapeutics Basic Information, Area Served and Competitors
    Table 78. SillaJen Biotherapeutics Major Business
    Table 79. SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Services
    Table 80. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. SillaJen Biotherapeutics Recent Developments/Updates
    Table 82. SillaJen Biotherapeutics Competitive Strengths & Weaknesses
    Table 83. Sorrento Therapeutics Basic Information, Area Served and Competitors
    Table 84. Sorrento Therapeutics Major Business
    Table 85. Sorrento Therapeutics Oncolytic Virus Therapy Product and Services
    Table 86. Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Sorrento Therapeutics Recent Developments/Updates
    Table 88. Sorrento Therapeutics Competitive Strengths & Weaknesses
    Table 89. Lokon Pharma Basic Information, Area Served and Competitors
    Table 90. Lokon Pharma Major Business
    Table 91. Lokon Pharma Oncolytic Virus Therapy Product and Services
    Table 92. Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Lokon Pharma Recent Developments/Updates
    Table 94. Lokon Pharma Competitive Strengths & Weaknesses
    Table 95. Genelux Corporation Basic Information, Area Served and Competitors
    Table 96. Genelux Corporation Major Business
    Table 97. Genelux Corporation Oncolytic Virus Therapy Product and Services
    Table 98. Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Genelux Corporation Recent Developments/Updates
    Table 100. Genelux Corporation Competitive Strengths & Weaknesses
    Table 101. Vyriad Basic Information, Area Served and Competitors
    Table 102. Vyriad Major Business
    Table 103. Vyriad Oncolytic Virus Therapy Product and Services
    Table 104. Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Vyriad Recent Developments/Updates
    Table 106. Vyriad Competitive Strengths & Weaknesses
    Table 107. TILT Biotherapeutics Basic Information, Area Served and Competitors
    Table 108. TILT Biotherapeutics Major Business
    Table 109. TILT Biotherapeutics Oncolytic Virus Therapy Product and Services
    Table 110. TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. TILT Biotherapeutics Recent Developments/Updates
    Table 112. Cold Genesys Basic Information, Area Served and Competitors
    Table 113. Cold Genesys Major Business
    Table 114. Cold Genesys Oncolytic Virus Therapy Product and Services
    Table 115. Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 116. Global Key Players of Oncolytic Virus Therapy Upstream (Raw Materials)
    Table 117. Oncolytic Virus Therapy Typical Customers
List of Figure
    Figure 1. Oncolytic Virus Therapy Picture
    Figure 2. World Oncolytic Virus Therapy Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Oncolytic Virus Therapy Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Oncolytic Virus Therapy Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Oncolytic Virus Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Oncolytic Virus Therapy Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Oncolytic Virus Therapy Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Oncolytic Virus Therapy Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Oncolytic Virus Therapy Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Oncolytic Virus Therapy Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Oncolytic Virus Therapy Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Oncolytic Virus Therapy Revenue (2019-2030) & (USD Million)
    Figure 13. Oncolytic Virus Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Oncolytic Virus Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Oncolytic Virus Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Oncolytic Virus Therapy by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Oncolytic Virus Therapy Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Oncolytic Virus Therapy Markets in 2023
    Figure 27. United States VS China: Oncolytic Virus Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Oncolytic Virus Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Oncolytic Virus Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Oncolytic Virus Therapy Market Size Market Share by Type in 2023
    Figure 31. HSV-based Oncolytic Viruses
    Figure 32. Adenoviruses-based Oncolytic Viruses
    Figure 33. Vaccinia Virus-based Oncolytic Viruses
    Figure 34. Vesicular Stomatitis Virus-based Oncolytic Viruses
    Figure 35. Newcastle Disease Virus-based Oncolytic Viruses
    Figure 36. World Oncolytic Virus Therapy Market Size Market Share by Type (2019-2030)
    Figure 37. World Oncolytic Virus Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 38. World Oncolytic Virus Therapy Market Size Market Share by Application in 2023
    Figure 39. Melanoma
    Figure 40. Prostate Cancer
    Figure 41. Breast Cancer
    Figure 42. Ovarian Cancer
    Figure 43. Others
    Figure 44. Oncolytic Virus Therapy Industrial Chain
    Figure 45. Methodology
    Figure 46. Research Process and Data Source

Companies Mentioned

Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys